Conferences
ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
2018 Genitourinary Cancers Symposium
8 - 10 Feb 2018
Moscone West Building, San Fancisco, United States of America
Management of marker negative stage II testicular cancer
Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada
16 Mar 2018
Expert insight: Metastatic hormone sensitive prostate cancer latest
Professor Karim Fizazi and Professor Nicholas James
10 Feb 2018
Focus on non-metastatic castration resistant prostate cancer
Professor Noel Clarke and Dr Eric Small
10 Feb 2018
Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial ...
Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
9 Feb 2018
Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma
Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada
9 Feb 2018
Genetic mutations: New therapeutic avenues in metastatic prostate cancer
Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
9 Feb 2018
6-factor prognostic model for patients with advanced urothelial carcinoma
Dr Gregory Pond - McMaster University, Hamilton, Ontario
9 Feb 2018
Comment: Urothelial cancer research from ASCO GU 2018
Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
9 Feb 2018
VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and meta...
Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK
9 Feb 2018
Genomic profiling of muscle invasive bladder cancer to predict response to bladd...
Dr David Miyamoto - Massachusetts General Hospital, Boston, USA
9 Feb 2018
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in me...
Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA
9 Feb 2018
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amp...
Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium
9 Feb 2018
Serum miRNA to predict post-chemotherapy viable disease in testicular non-semino...
Dr Ricardo Leão - University of Toronto, Toronto, Canada
8 Feb 2018
Radium-223 for bone predominant metastatic castration resistant prostate cancer
Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA
8 Feb 2018
FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically recurre...
Dr Eugene Teoh - University of Oxford, Oxford, UK
8 Feb 2018
PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future t...
Dr Lauren Harshman - Dana-Farber Cancer Institute, Boston, USA
8 Feb 2018
POUT: Phase III randomised trial of perioperative chemotherapy vs surveillance i...
Dr Alison Birtle - Lancashire Teaching Hospitals NHS Foundation Trust, Lancashir...
8 Feb 2018
Updates on non-metastatic castration-resistant prostate cancer
Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small
8 Feb 2018
Latest in adjuvant therapy for renal cell carcinoma
Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA
8 Feb 2018
Updates in metastatic prostate cancer
Prof Heather Payne, Dr Neal Shore, Dr Eleni Efstathiou, Prof Nicolas Mottet
8 Feb 2018
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for...
Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK
8 Feb 2018
